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ABSTRACT  
Background: Despite their potential, there is limited uptake of formal qualitative methods in model 
development by modellers and health economists. The aim of this case study is to highlight in a real-
world context how a qualitative approach has been applied to gain insight into current practice 
(delineating existing care pathways) for typhoid fever in Ghana which can then assist in model 
structure conceptualisation in a model-based cost-effectiveness analysis. 
Methods: The perspectives of a range of healthcare professionals working in different settings and 
across different practices in the Eastern region of Ghana were captured with a self-administered 
survey using open-ended questions and analysed using the framework method. 
Results: A total of 51 completed questionnaires were retrieved representing a 73% response rate. It 
was found that two main care pathways for typhoid fever exist in Ghana and there was no consensus 
on how a new test might be applied to the existing pathways.  
Conclusion: The two settings in Ghana have different care pathways and any cost-effectiveness 
analysis should consider the alternative pathways separately. This study has demonstrated that 
framework analysis is a qualitative methodology that is likely to be accessible and feasible across a 
wide range of health economic settings.  
Key points for Decision Makers 
• Delineating care pathways during model development can be difficult and qualitative methods 
play a potentially key role in enhancing this process. 
• Integrating qualitative methods in model development can potentially enhance the validity as well 
as generalizability and credibility of models. 
• Framework analysis is a simple but systematic qualitative approach that can potentially enhance 
the process of model development.     
Key words: qualitative techniques; framework method; model development; cost-effectiveness; care 
pathways; typhoid fever 
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1.0 INTRODUCTION 
There exist challenges for health economic evaluation of medical tests [1]. Direct research 
required for their evaluation is lacking [2]. Therefore, test evaluation in most cases generally 
involves modelling of test-treat pathways by integrating evidence from studies evaluating one 
or more aspects (test accuracy, test performance, treatment effectiveness) within the care 
pathway [3]. An informative economic model will require knowledge of care pathways if it is 
to represent appropriately the disease, persons not having the disease, misclassifications, and 
be fit for the purpose of decision making [4]. Therefore, delineating the care pathway and any 
existing variations may be a key information requirement to effective test evaluation [5].  
Delineating the test-treat pathway can be difficult and qualitative methods can play a 
potentially key role in enhancing this process [6-10]. For example, they can be used to 
facilitate and capture the perspectives of all of the different types of experts knowledgeable 
on the topic of interest [11], including capturing variability in practice when defining care 
pathways to assist in model structure conceptualisation [12]. Variability may arise from 
clinicians and patients involved at different points in a care pathway and in different 
settings/locations. Capturing variability can potentially assist in improving the validity as 
well as generalizability and credibility of models. There are examples of different qualitative 
research methods used for model development including the Delphi technique [12,13], focus 
groups [8], and stakeholder workshops [14]. Despite their potential, there is limited uptake of 
formal qualitative methods in model development by modellers and health economists [15]. 
One explanation for their limited uptake is lack of familiarity of their potential to assist with 
model development and a general assumption that qualitative methods are resource intensive. 
The diagnosis of typhoid fever represents an area of unmet need in Ghana [16]. The 
investigative tool most often used is the Widal test (a serological test). Typhoid fever has 
been over diagnosed based on the Widal test [17], and the WHO recommended investigative 
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tool (blood culture) [18] has its limitations. Low sensitivity (the ability of the test to correctly 
classify the proportion of people with disease who will have a positive test result) remains a 
limitation to this diagnostic method (as low as 40%) [19]. The potential impact is that, the 
disease will be missed in a lot of patients (i.e., a high false negative rate) resulting in lost 
opportunity for treatment, which might lead to increased morbidity and mortality. 
Furthermore, culture testing requires resources (trained personnel and equipment) which may 
not be available in primary health care facilities in Ghana (as in other resource-constrained 
settings) and results take 2-3 days. This may result in diagnosis being delayed or overlooked, 
and patients may end up with complications if treatment is postponed or patients are lost to 
follow up [20]. Typhoid fever clinically resembles other febrile conditions such as malaria 
and is easily misdiagnosed without laboratory confirmation [21], which could lead to an 
overprescribing of antimalarial therapies associated with a huge economic impact on the 
Ghanaian economy. Consequently, concerted efforts are being made to develop a clinically 
effective and cost-effective rapid diagnostic test that will aid fast accurate diagnosis and 
management of typhoid fever cases in Ghana.  
Identifying care pathways for typhoid fever in Ghana, their variations, diagnostic challenges 
associated with these (which are likely to result from the different levels of care) and the 
potential placement and role (replacement, triage or add-on) of a new test on existing care 
pathways are key to the effective evaluation of the true value of a new test. This requires 
novel research because records cannot be relied on to obtain such relevant information. The 
characteristics of a test: accuracy (sensitivity, specificity) and processing requirements (for 
example expertise, equipment needed, and time taken) will determine the best placement and 
role on a testing pathway. A test intended to be a replacement test is expected to be more 
accurate, less invasive for the patient and yields quicker results. A test intended to be a triage 
test may be less accurate than existing ones, should be non-invasive, simple to perform and 
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cheap. A test may be used as an add-on test at the end of a testing pathway because although 
it is more accurate, it is also more invasive or expensive. Consequently, its application is 
reserved for specific patient subgroups in which the test is deemed a final resort [22].  
The aim of this case study is to highlight in a real-world context how a qualitative approach 
has been applied to gain insight into current practice (delineating existing care pathways) for 
typhoid fever in Ghana and the potential role of a hypothetical test on the pathway, which can 
then assist in model structure conceptualisation in a model-based cost-effectiveness analysis. 
Specifically, the aim is to describe the existing care pathway for typhoid fever in Ghana and 
any variations, explore reasons for variations in existing care pathways for typhoid fever in 
Ghana, and to capture the views of a range of healthcare professionals working in Ghana on 
the potential role of a hypothetical new rapid test for typhoid in the care pathway they work 
in.   
2.0 METHODS  
The perspectives of a range of healthcare professionals working in different settings and 
across different practices in the Eastern region of Ghana were explored to answer the 
questions: what is the test-treat pathway for typhoid fever in Ghana? Are there variations in 
the existing test-treat pathway? And what is the potential role(s) of a new test on the existing 
pathway in Ghana? One region was chosen as a case study because the literature on the 
structure of the healthcare delivery system in Ghana indicated that variations in practice were 
likely to result from the different levels of care (which is the same across all the regions) 
rather than resulting from the individual regions. The Eastern region was selected because the 
Principal Investigator (PI) worked and lived in this region and is familiar with the region thus 
it was comparatively less resource intensive to obtain the data required because of proximity. 
A purposive, maximum variation sampling approach (which involves approaching all those 
who are knowledgeable on the topic on interest and can give potentially different 
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perspectives) was undertaken [11]. The results were compared between settings as this was 
considered the main factor likely to drive any variations in the findings.     
2.1 Participants 
To be eligible for inclusion in the study, the participant had to be a clinician or medical 
assistant who worked in a healthcare provision facility (Health Centre, Polyclinic, hospitals, 
etc.) in the Eastern region of Ghana. Clinicians and medical assistants were chosen to 
participate in this study because they were knowledgeable in the topic of interest and thus 
were in a better position to provide valuable information to aid this study. Participants of all 
ages and genders were included to avoid sampling bias.  
2.2 Data collection (March – July 2017) 
Some level of pragmatism was required to choose the most appropriate approach to collect 
data. In-depth interviews were not possible because of participants’ time constraints. 
Therefore a self-administered survey using open-ended questions was used [23]. 
Acknowledging that responses were likely to lack depth, and a survey would not allow 
probing by the researcher or checking of the participants’ understanding of the questions, a 
well written questionnaire was required to elicit adequate valuable information. A 
questionnaire was piloted in a different region (Greater Accra) and revised based on 
responses into the final version used in this study. With ethical approval from the University 
of Birmingham (ERN_16-0947) and from the Ghana Health Service Ethical Review 
Committee (GHS-ERC: 03/12/16), medical superintendents of various health facilities were 
contacted to arrange a meeting between the researcher and the clinicians and/or medical 
assistants working at their facilities. During these meetings, the aims and the expected 
outcomes of the study were explicitly explained to them and interested persons were recruited 
into the study after having gone through the informed consent process and signed the consent 
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form. Groups of recruited participants in each institution were given the opportunity to go 
through the questionnaire to ensure they understood the questions, and explanations were 
offered to clarify issues where necessary. Questionnaires were coded for easy identification 
of the facility and its location within the region to enable easy analysis of the data. 
Participants were anonymized. A total of 70 self-administered questionnaires were distributed 
to participants by the researcher in person.              
The following themes were generated a priori by the research team and informed the content 
of the questionnaire: presumptive treatment views (treatment of clinically suspected cases 
without, or prior to, results for confirmatory laboratory test), diagnostic test(s) used, test 
negative management (care plan for those with negative test result), test positive management 
(care plan for those with positive test results), prescribed antimicrobial for positives, dosage 
of antimicrobial, assessment of test-treat outcome and intended role of new test. All the 
themes except for “intended role of new test” were generated to gain insight into current 
practice by considering them collectively and thus are reported and discussed under the 
section “delineating existing test-treat pathway and reasons for variation”. “Intended role of 
new test” was examined to capture views on the potential role of a hypothetical new test, and 
where it should be placed on the testing pathway to improve current practice. The chosen role 
of a new test implies the necessary properties it should possess. Participants were asked to 
choose a statement which best describes the role of a hypothetical new rapid diagnostic test 
for typhoid: (a) to test patients first to decide on who should receive further testing with the 
test you use now (triage); (b) as the main investigative tool without further testing with the 
test you use now (replacement); or (c) to provide additional diagnostic information after 
testing with the test you use now (add-on). The questionnaire is shown in Appendix 1. 
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2.3 Data analysis 
Framework analysis was adopted as the analytical framework for analysing the data collected 
in this study [24]. This method of analysis belongs to a wider group of analysis methods 
(termed thematic analysis or quantitative content analysis) which seeks to identify, analyse 
and report patterns within data [25]. The data collected is based on pre-defined themes 
(deductive) rather than inductive (emerging from the data). The distinctive attribute of this 
method is the matrix output, which provides a systematic structure into which data can be 
charted (inputted) to enable in-depth analysis [26]. It consists of rows, columns and cells of 
summarised data. In this case study, rows referred to participants, columns referred to pre-
defined themes, and cells of summarised data referred to responses from participants. 
Framework analysis was chosen due to its deductive approach that makes it especially suited 
to research that has specific data needs set in advance [27]. In this case study, it allowed for 
pre-defined themes to be developed which shaped the nature of the data collection. In 
addition, framework analysis was selected because it is intuitive and allows for easy 
recognition of patterns in the data set once a matrix has been developed [24]. Also, the 
systematic approach embedded in the framework method of analysis ensures that the rigour 
of the analytical process is maintained, thereby enhancing the credibility of findings [28]. 
Figure 1 illustrates the procedure for analysis using the framework approach.  
Written responses retrieved from participants were first converted into electronic form by the 
principal researcher and read repeatedly by members of the research team to ensure 
familiarisation with the data. This provided a good opportunity to get immersed in the data 
set and have a better recollection of key information [25]. The textual data was colour coded 
(by two members of the research team individually) to classify all of the data set according to 
the pre-defined themes. There were no emerging new themes from the survey, thus, the pre-
defined themes generated were then developed into a working analytic framework; a matrix 
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consisting of rows and columns into which data was charted to enable in-depth analysis [26]. 
The “analytical framework matrix” is shown in Appendix 2.  
3.0 FINDINGS  
3.1 Demographics of participants 
A total of 51 questionnaires were retrieved representing a 73% response rate. Non-
respondents were all participants working in primary hospitals and time constraint was the 
main reason given for non-response. Twenty responses were from participants working in 
secondary care and thirty-one from participants in primary care. The name, gender, and age 
of the participants were not captured to ensure participant anonymity.  
3.2 Delineating existing test-treat pathway and reasons for variations 
In terms of gaining insight into current practice two main care pathways were delineated from 
the analysis of the matrix; the “culture care pathway” (suspected typhoid cases have culture 
i.e., blood, stool or urine) and the “Widal care pathway” (suspected typhoid cases have Widal 
test) (Fig 2&3). Underpinning this variation was the type of healthcare provision facility in 
which the participants were recruited from. It was noted that the “Widal care pathway” was 
predominantly followed in primary hospital facilities (typically district level facilities that 
provide the most basic care) whereas the “culture pathway” was predominantly followed in 
the secondary hospital facility (typically regional hospitals which are an upgrade of primary 
hospitals in terms of infrastructure and resources). However, there were two exceptions to 
this pattern. Blood or stool culture was stated by participant 50 (P) as the diagnostic tool 
used even though the participant was recruited from a primary hospital facility and 
participant 31(S) stated the use of the Widal test even though the participant was recruited 
from a secondary hospital facility (letters P and S in parenthesis indicate whether a 
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participant was recruited from primary care or secondary care respectively). Participant 
31(S) stated, “it is the commonest and simple to do” as the reason for using the Widal test. 
This quote is suggestive of the fact that the Widal test could be available in secondary 
hospitals even though culture might be the preferred test in such settings. Participant 50(P) 
stated, “it is readily available in our lab” as the reason for employing culture.  
The management aspect of the two care pathways following testing with either the Widal test 
or culture was found to be similar. In both pathways, test negative patients were investigated 
further for other conditions especially malaria and treated according to the final diagnosis. 
For example, participant 16(P) stated, “when negative, we check for other conditions like 
malaria and treat them”. Participant 19(P) stated, “I look out for other conditions 
presenting like typhoid fever in typhoid negative clients and treat”. Participant 35(S) stated, 
“when negative I investigate underlying cause of symptoms and treat appropriately”. And 
participant 38(S) stated, “when negative, I investigate further to get the specific condition”. 
Typhoid positive patients were noted from the analysis to be treated with antibiotics mainly 
oral ciprofloxacin at a dose of 500mg every twelve hours for a period of seven to fourteen 
days. After this, they were reviewed and in most cases re-tested to ascertain whether the test-
treat process was successful in improving the patient’s health. For example, participant 
19(P) stated, “I treat typhoid positive patients with oral ciprofloxacin. Dosage: Tb 
Ciprofloxacin 500 mg bd* 7-14 days”. Participant 25(P) stated, “positives: I treat with 
ciprofloxacin. Dosage: Tb Ciprofloxacin 500mg bd *14 days”. And participant 32(S) stated, 
“I give oral antibiotics medication for positive patients. Dosage: Tb Ciprofloxacin 500 mg 
bd* 10 days”. It was noted that, the choice of oral ciprofloxacin was because it is the first line 
drug to manage typhoid fever and for other reasons such as its efficacy against the causative 
organism, availability and cost. For example, participants 31(S) and 51(P) stated, “it is the 
first line drug to manage typhoid”. And participant 33(S) stated, “because of its efficacy and 
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sensitivity against the causative organism Salmonella typhi”. However, it was noted that 
some participants prescribed alternative antibiotics to oral ciprofloxacin. For example 
participant 1(P) stated, “positive cases are put on treatment. Dosage: Tb Metronidazole 
200-400mg tds* 7days”. Participant 4(P) stated, “treat positives with antimicrobials. 
Dosage: Tb Cefixime 200mg bd*7 days”. Participant 8(P) stated, “I give antibiotics for test 
positive cases. Dosage: Tb Azithromycin 1g daily* 7days”. And participant 30(S) stated, 
“positives: I give antibiotics. Dosage: Tb Cefixime 400mg bd*10-14 days”. 
Of further interest was the views of participants on applying presumptive treatment for 
typhoid fever. The majority of participants were averse to presumptive treatment, because 
they expressed the opinion that this may lead to treatment failure and the development of 
antimicrobial resistance. For example, participant 18(P) stated, “it could lead to treatment 
failure and antimicrobial resistance”. Participant 28(S) stated, “it can cause antibiotic 
resistance”. Participant 11(P) stated, “presumptive treatment may be prophylactic but can 
cause antimicrobial resistance”. And participant 1(P) stated, “typhoid fever presents like 
malaria and presumptive treatment may lead to treatment failure”. A very few advocated for 
presumptive treatment, but then only under certain circumstances. For example, participant 
50(P) stated, “since culture usually takes 72 hrs, presumptive treatment can be started”. 
Participant 30(S) stated, “this is a good intervention to prevent complications since the most 
precise blood/stool cultures are not available in most district and health centres”. And 
participant 23(P) stated, “Widal test is not solely reliable hence treatment can be made if 
test is not done but clinical features are present”. From these quotes, it can be concluded that 
presumptive treatment appears to be used because of delays in diagnosis or concerns about 
the accuracy of the test or lack of availability.  
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3.3 Perceived role of new test  
Twenty-eight participants from different levels of care stated that they saw themselves using 
a new test, “to provide additional diagnostic information after testing with the test they were 
using currently (add-on)”. Sixteen participants from the different levels of care stated that 
they saw themselves using a new test, “To test patients first to decide on who should receive 
further testing with the test you use now (triage)”. And six participants from the different 
levels of care stated that they saw themselves using a new test, “as the main investigative tool 
without further testing with the test they were using currently (replacement)”. This 
observation was further explored according to health care setting and it was found that there 
was a similar trend in the response by health care setting.  
The chosen role of a new test implies the necessary properties it should possess. Thus, 
participants’ views on what test properties the new test should possess were explored. The 
majority of the participants wanted the new test to be more sensitive followed by those who 
wanted it to be more specific (the ability of a test to correctly classify the proportion of people 
without the disease who will have a negative test result) with participants 8(P) and 30(S) 
stating that they wanted the new test to be more sensitive and more specific compared to the 
test they were currently using. Some other properties as stated by the participants were 
improved reliability, low cost, greater availability, better accuracy, the ability to use other 
fluids apart from blood, easy to use, fast results, and high predictive values. It was noted that 
for some participants, their views on what test properties a new test should have did not 
correspond with their choice of the role of the test. For example participant 37(S) stated 
“better accuracy, low cost, accessibility and ease to perform” as the properties of the new 
test but wanted the test to be used as an add-on to culture. However, it is intuitive from the 
stated properties that this test should ideally be placed before culture in the care pathway to 
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expedite clinical decision making and enhance prompt implementation of an appropriate 
effective treatment.  
4.0 DISCUSSION 
An in-depth understanding of test-treat pathways is key to fully capturing the potential health 
economic impact of medical tests on patient relevant outcomes, and qualitative methods play 
a potentially key role in enhancing this process despite their limited uptake in practice. This 
case study focussed on how a qualitative approach has been applied to gain insight into 
current practice for typhoid fever in Ghana and the potential role of a new test on the care 
pathway in order to improve current practice. It was noted that two main care pathways for 
typhoid fever in Ghana exist (Widal and culture pathways) and the majority of the 
participants in this study were averse to applying presumptive treatment to typhoid fever. 
Also, it was noted that the majority of participants saw themselves using a new rapid test if it 
was introduced into clinical practice as an add-on test followed by those who anticipated 
using it for the purpose of triage, with very few of the participants using it as a replacement to 
the test they were currently using.   
The identification of two main pathways in this study was primarily due to variations in 
laboratory diagnostic capacity of healthcare facilities from which the participants were 
recruited. The Widal test is a simpler technology to employ compared to culture which 
requires resources (trained personnel and equipment) and therefore was more likely to be 
employed in primary hospitals which lack resources whereas culture was more likely to be 
employed in secondary hospitals. Although the majority of participants were averse to 
applying presumptive treatment to typhoid fever, a few advocated for presumptive treatment 
and for valid reasons such as delays in diagnosis or concerns about accuracy of test or lack of 
availability. These circumstances reflect the characteristics of current practice and therefore a 
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new test would need to be “better” in these respects for healthcare professionals in Ghana to 
use if current practice is to be improved. The test should have a quick turnaround time, at 
least as accurate (as both tests) if not more accurate and should be accessible. Improved 
reliability, low cost, greater availability, better accuracy, the ability to use other fluids apart 
from blood, easy to use, fast results, and high predictive values were mentioned as the 
properties that a new test should have to improve current practice. These findings are key 
information that need to be taken into consideration in any effort to develop a new test to be 
used in the Ghanaian setting. The use of alternative antimicrobials to ciprofloxacin as noted 
from this study demonstrates the potential for waste in current practice, indicating the need 
for standardisation in, or adherence to, the treatment regimen for typhoid fever patients. 
Furthermore it was noted that regardless of the setting,  majority of participants saw 
themselves using a new rapid test if it was introduced into clinical practice as an add-on test, 
followed by those who anticipated using it for the purpose of triage, with very few of the 
participants using it as a replacement to the test they were currently using. However, one 
would have expected the responses to vary depending on the care pathway in which the 
participant worked. Underpinning this viewpoint is the fact that, if the main limitation of the 
Widal test as acknowledged by the participants who follow the “Widal care pathway” is 
unreliability of the test, then a majority of them should be more inclined towards using a new 
test which is intended to be more reliable as their main investigative tool rather than as an 
add-on to the test. The argument might be that the very limitation of the Widal test is the 
reason why the new test should be used to provide additional diagnostic information. 
However, if the new test is accurate enough to be used to confirm diagnosis after the Widal 
test, then it is intuitive that it will replace the Widal test to save money (although it is 
acknowledged that a cost-effectiveness analysis comparing both tests will be needed to make 
such a decision). Also, for those participants who follow the “culture pathway” one would 
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have expected the majority of them to be more inclined towards using the new test for triage 
purposes. The reasoning is that, if culture takes 2-3 days (causing potential treatment delays), 
then it is intuitive that patients would be tested first with the proposed test and test positive 
patients treated promptly whilst test negative patients could be further tested by having their 
samples cultured. However, it was not possible to explore the reasoning behind the 
participants’ choices (which could be lack of understanding, perception of the accuracy of the 
existing tests, scepticism about the reality of a new test, acceptability and accessibility of new 
test).  
The findings from this survey can inform the subsequent modelling process in a number of 
ways. First, delineated test-treat pathways can inform and assist in defining the boundaries 
and structures of the individual models needed to effectively evaluate the true value of a 
hypothetical test. It will inform the model structure to appropriately represent clinical 
practice.  These findings indicate that the settings in Ghana are different depending on the 
level of care, and the implication is that any cost-effectiveness analysis should consider these 
alternative pathways separately. Second, the findings of the study have assisted in identifying 
the appropriate comparator test strategies required for the cost-effectiveness study. The 
potential cost-effectiveness of the hypothetical test should be evaluated by comparing it with 
each comparator testing strategy separately. This will inform decision making on how the 
new test should be used in each care pathway, i.e., should it replace the Widal test or should it 
be used as a replacement, triage or add-on test to blood culture? Furthermore, the intended 
role of a new test in a care pathway should be clearly defined in the model to enable the 
assessment of the test in that role. The study findings indicate there was no consensus among 
the participants on what this role should be, suggesting the need to evaluate the test in all the 
possible roles in each pathway. It is not clear whether these responses were due to lack of 
understanding. However, this does not undermine the need to evaluate all possible roles of a 
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new test. Figures 4, 5 & 6 shows the various model structures evaluating all possible roles of 
a new test.   
Adopting the framework method has worked well for this particular case study. The relatively 
well structured and deductive approach to questioning enhanced the efficiency of the data 
collection process because it allowed for the information requirements to be well specified in 
advance which shaped the nature of the data to be collected. Furthermore, the matrix output 
allowed patterns to be more easily identified. For example, it was easy to identify the test-
treat pathways once the matrix had been developed and data charted into it. An open-ended 
approach to questioning also allowed the identification of unanticipated issues. An example is 
the observation with regards to the use of alternative antibiotics to ciprofloxacin.  Also, 
adopting the framework approach allowed for the perspectives of fifty-one participants 
working in different settings/locations and across different practices (rather than a few 
informants) to be captured and analysed to gain in-depth understanding of current practice. 
The implication is that, it could potentially enhance the validity, generalizability and 
credibility of findings of any modelling study based on the delineated pathways.   
Furthermore, many techniques that might be used to elicit test-treat pathways may not be 
feasible due to time and resource (money and skill) constraints. For example, there are 
challenges such as the practicality of organising and running face-to-face discussions in focus 
groups or gaining the inputs of multiple clinicians with busy schedules by asking them to 
complete questionnaires in a series of rounds as in the Delphi approach. However, as has 
been shown in this study, framework analysis is an example of a qualitative methodology that 
is likely to be accessible and feasible across a wide range of health economic settings. The 
framework method of analysis can in principle be adapted for the analysis of different forms 
of textual data (e.g., interview transcripts, responses to a questionnaire, meeting minutes and 
field notes from observations) to produce highly structured outputs of summarised data across 
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a range of research areas [29]. The key aspect of framework analysis within qualitative 
research is that it is deductive and allows the researcher to collate qualitative information 
within pre-defined categories or themes. This is one of the key characteristics of framework 
analysis that potentially makes it more accessible to quantitative researchers. Thus for this 
method to be beneficial in any specific health economics context, it is necessary for the 
researcher to be clear from the outset the issues to be explored (such as the purpose of the 
model, the type of model to be developed, what elements are heterogeneous etc.). This will 
inform the most appropriate questions to ask during data collection in order to collect relevant 
data. Once data has been collected and converted into textual form, the framework method 
can be applied to analyse the data set to generate important outputs that will appropriately 
inform the model development process. It is worth mentioning that when reporting qualitative 
research finding, usually the researcher describes and interprets quotes as they are not self-
explanatory without context. However as seen in this study, a survey rather than interviews 
was conducted and therefore there is limited interpretation. This is due to the nature of the 
questions asked, eliciting responses that were quite straight forward and requiring less 
interpretation.  
The literature suggests two main ways in which qualitative methods can be applied to the 
model process. Indeed, there are several studies where the benefits of the application of 
qualitative methods in model development have been highlighted. For example, Kaltenhaler 
et al [7] reviewed responses of the evidence review groups (ERGs) (of the National Institute 
for Health and Care Excellence (NICE)) to manufacturers’ model submissions using 
documentary analysis. They identified several recurring concerns raised by ERGs and made 
some recommendations to assist manufactures to improve the quality of their submissions. In 
this instance, a qualitative approach was used to identify and understand areas of concern that 
required further guidance to inform general and future modelling processes. The Delphi 
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technique has been demonstrated by Sullivan and Payne [13] and Iglesias et al [12] as a 
means to gain consensus and collate experts’ opinions on certain aspects of a model structure, 
while the focus group approach for the conceptualisation of models structure has been 
demonstrated by Roberts et al [8], and Squires et al [14] thus demonstrating the use of 
stakeholder workshops to conceptualise model structure. Furthermore, there is an increasing 
reliance on expert judgement as a useful source of data for economic models [13], 
particularly in early-modelling studies and in cost-effectiveness studies of technologies 
conducted in the absence of data from randomised controlled trials. Expert judgement is 
relied on not only to structure and populate a model but also on other important parameters 
(such as test accuracy) which have an impact on care pathways. Qualitative approaches 
provide a robust and explicit way to properly elicit their opinions. Clearly, the benefits of 
using qualitative approaches to inform model development cannot be relegated to the 
background.    
The limitations of this study include the fact that only clinicians and medical assistants were 
sampled. Other relevant stakeholders such as patients [30] and policy makers could have also 
been sampled because they may have held different views or added further considerations. 
Furthermore, because the interviews were not personally conducted, it was not clear whether 
the participants actually understood all the questions and it was not possible to probe their 
responses. This was a particular deficiency in this study when capturing valid participants’ 
views about the anticipated role of a new test. 
5.0 CONCLUSION 
Delineating care pathways during model development can be difficult and qualitative 
methods can play a potentially key role in enhancing this process. Integrating qualitative 
methods in model development can potentially assist in improving the validity as well as 
generalizability and credibility of models. As shown in this case study, qualitative methods 
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lend themselves well to facilitating the involvement of the different types of experts 
knowledgeable on a topic on interest and working in different settings (rather than a few 
informants) to be captured and analysed, thereby potentially enhancing the credibility of the 
models developed based on the findings.  
The qualitative method applied in this study is a simple but systematic approach that can 
potentially enhance the process of model development. As shown in this study, it provides an 
alternative way to eliciting responses from relevant stakeholders without having to run face-
to-face discussions or by asking them to complete questionnaires in a series of rounds which 
could be very tasking and time consuming. Thus, by adopting this method, modellers will 
avoid such additional burden associated with other methods (a possible explanation for the 
reduced uptake of formal qualitative approaches in model development) whilst still being 
able to collect and analyse such in-depth information to gain insight into current practice. 
One of the defining features of the framework method as highlighted in this study is that, it 
can be adapted for the analysis of different forms of textual data and it provides explicit steps 
to follow to produce highly structured outputs of summarised data. Once the matrix has been 
developed and data charted into it, recognition of patterns in the data set becomes quite 
straightforward because it becomes easier to compare data across cases and within cases. 
Therefore, this useful approach could be adopted by health economists and modellers who 
may want to undertake such studies because of their potentially important role in enhancing 
model credibility. 
Clearly, qualitative methods can potentially assist in improving the model development 
process and we suggest that those working in this field consider the opportunities that 
qualitative methods provide. Qualitative investigation is a step beyond the usual informal 
discussions with clinicians that informs modelling. 
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